540359 — Parmax Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹938.28m
- IN₹1.05bn
- IN₹121.12m
Annual cashflow statement for Parmax Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | R2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 0.461 | -56.6 | -20.9 | -41.6 |
| Depreciation | ||||
| Non-Cash Items | -1.85 | 0 | 7.71 | -16.9 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | -14.1 | 37.5 | -3.65 | 24.8 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 3.33 | -1.9 | -6.56 | -23.6 |
| Capital Expenditures | -9.36 | -15.9 | -7.01 | -9 |
| Purchase of Fixed Assets | ||||
| Cash from Investing Activities | -9.36 | -15.9 | -7.01 | -9 |
| Financing Cash Flow Items | — | — | -4 | 0 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -0.442 | 14.3 | 14 | 38.1 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -6.47 | -3.5 | 0.393 | 5.59 |